Back
CVS Health Quote, Financials, Valuation and Earnings
Sponsored
CVS
Sponsored
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Sell
32
CVS
CVS Health
Last Price:
55.90
Seasonality Move:
1.63%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!CVS Health Price Quote
$55.90
CVS Health Key Stats
Sell
32
CVS Health (CVS)
is a Sell
Day range:
$54.96 - $56.43
52-week range:
$53.70 - $83.25
Dividend yield:
4.54%
P/E ratio:
8.64
P/S ratio:
0.20
P/B ratio:
0.95%
Volume:
23.6M
Avg. volume:
12.3M
1-year change:
-20.23%
Market cap:
$70.2B
Revenue:
$357.8B
EPS:
$5.69
How Much Does CVS Health Make?
-
How Much Are CVS Health's Sales Annually?
CVS Revenues are $357.8B -
How Much Profit Does CVS Health's Make A Year?
CVS net income is $8.3B
Is CVS Health Growing As A Company?
-
What Is CVS Health's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04% -
What Is CVS Health's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.47%
CVS Health Stock Price Performance
-
Did CVS Health Stock Go Up Last Month?
CVS Health share price went down by -25.07% last month -
Did CVS's Share Price Rise Over The Last Year?
CVS share price fell by -20.23% over the past 1 year
What Is CVS Health 52-Week High & Low?
-
What Is CVS Health’s 52-Week High Share Price?
CVS Health has traded as high as $83.25 over the past 52 weeks -
What Is CVS Health’s 52-Week Low Share Price?
CVS Health has traded as low as $53.70 over the past 52 weeks
CVS Health Price To Free Cash Flow
-
Is CVS Health Stock Overvalued?
CVS Health is trading at a price to free cash flow ratio of 8.82 -
Is CVS Health Stock Undervalued?
CVS Health EV to Free Cash Flow ratio is 14.92 -
What Is CVS Health’s Price Earnings Growth Ratio?
CVS PEG ratio is 0.12 -
Is CVS Health Trading At A Premium To Earnings?
CVS Health EV to EBIT ratio is 9.59
Is It Risky To Buy CVS Health?
-
How Much Debt Does CVS Health Have?
Total long term debt quarterly is $64.1B -
How Much Cash Does CVS Health Have?
Cash and short term investments quarterly total is $13.1B -
What Is CVS Health’s Book Value Per Share?
Book value per share is 59.08
Is CVS Health Cash Flow Positive?
-
What Is CVS Cash Flow From Operations?
Cash flow from operations (TTM) is $10.9B -
What Is CVS Health’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.3B -
What Is CVS Health’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$14.5B
CVS Health Return On Invested Capital
-
Is Management Doing A Good Job?
CVS return on invested capital is 5.39% -
What Is CVS Health Return On Assets?
ROA measures how assets are converting to revenues and is 2.95% -
What Is CVS Return On Equity?
ROE is a measure of profitability and is 9.9%
CVS Health Earnings Date & Stock Price
-
What Is CVS Health's Stock Price Today?
A single share of CVS can be purchased today for 55.90 -
What Is CVS Health’s Stock Symbol?
CVS Health trades on the S&P500 under the ticker symbol: CVS -
When Is CVS Health’s Next Earnings Date?
The next quarterly earnings date for CVS Health is scheduled on August 2, 2024 -
When Is CVS's next ex-dividend date?
CVS Health's next ex-dividend date is April 19, 2024 -
How To Buy CVS Health Stock?
You can buy CVS Health shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CVS Health Competitors
-
Who Are CVS Health's Competitors?
Below is a list of companies who compete with CVS Health or are related in some way:
CVS Health Dividend Yield
-
What Is CVS Dividend Yield?
CVS Health’s dividend yield currently is 4.54% -
What Is CVS Health’s Payout Ratio?
CVS Health’s payout ratio is 43.61% -
When Did CVS Health Last Pay A Dividend?
The latest dividend pay date is May 6, 2024 -
What Is CVS Health’s Dividend Per Share?
CVS Health pays a dividend of $0.67 per share
CVS Health Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -46.67% | -22.79% |
Revenue: | 3.7% | -0.86% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 11 |
Sell Recommendations: | 0 |
Price Target: | 74.21 |
Upside from Last Price: | 32.76% |